Metabolic Syndrome and Fatty Liver Disease Among Egyptian Patients with Chronic HBV
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorAssiut University
About this trial
1. investigate the Prevalence of combined hepatic steatosis in patients with chronic HBV. 2. to evaluate clinical characteristics of chronic HBV patients combined with metabolic syndrome and hepatic steatosis
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age above 18 years.
Disqualifiers
Age below 18 years.
Patients with combined HBV,HCV,HIV.
Patients refused to contribute in this study.
Trial population
total coverage of all patients with HBV aged 18-60 years,not combined with HCV or HIV.
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
investigate the Prevalence of combined hepatic steatosis in patients with chronic HBV
Time frame
baselineSecondary outcomes
1
evaluate clinical characteristics of chronic HBV patients combined with metabolic syndrome and hepatic steatosis
Time frame
baselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: